• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由人乳头瘤病毒16型E7衍生肽诱导的人细胞毒性T淋巴细胞的特异性

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.

作者信息

Jochmus I, Osen W, Altmann A, Buck G, Hofmann B, Schneider A, Gissmann L, Rammensee H G

机构信息

Deutsches Krebsforschungszentrum, Heidelberg, Germany.

出版信息

J Gen Virol. 1997 Jul;78 ( Pt 7):1689-95. doi: 10.1099/0022-1317-78-7-1689.

DOI:10.1099/0022-1317-78-7-1689
PMID:9225046
Abstract

In order to establish tumour-specific cytotoxic T lymphocyte (CTL) cell lines, T cells from a human papillomavirus (HPV) type 16-positive patient with a cervical carcinoma in situ and from a healthy volunteer were stimulated in vitro with autologous dendritic cells loaded with peptides derived from the viral transforming proteins E6 and E7 and corresponding to potential HLA-A0201-restricted T cell epitopes. From each donor a small number of low-affinity CTL lines against the peptide E7/86-93 was obtained, which specifically lysed HLA-A0201-expressing B-lymphocytes (cell line 721) loaded with this peptide. Cytotoxicity was also observed against two HLA-A*0201-E7-positive epithelial cell lines, the cervical carcinoma cell line CaSki and the HPV-16-immortalized foreskin-keratinocyte cell line HPK IA. However, since none of the CTL recognized both cell lines, and E7-expressing 721 transfectants were never lysed, it was concluded that the reactivity against CaSki and HPK IA cells was due to cross-reactivity on allogeneic HLA molecules rather than to E7 recognition, which emphasizes that the specificity of tumour cell lysis by peptide-induced CTL has to be interpreted with caution.

摘要

为建立肿瘤特异性细胞毒性T淋巴细胞(CTL)细胞系,从一名人乳头瘤病毒(HPV)16型原位宫颈癌患者及一名健康志愿者体内获取T细胞,在体外使用负载有源自病毒转化蛋白E6和E7且对应潜在HLA - A0201限制性T细胞表位的肽段的自体树突状细胞进行刺激。从每个供体获得了少量针对肽段E7/86 - 93的低亲和力CTL系,这些CTL系可特异性裂解负载该肽段的表达HLA - A0201的B淋巴细胞(721细胞系)。还观察到对两种HLA - A*0201 - E7阳性上皮细胞系的细胞毒性,即宫颈癌细胞系CaSki和HPV - 16永生化包皮角质形成细胞系HPK IA。然而,由于没有一个CTL能识别这两种细胞系,且表达E7的721转染细胞从未被裂解,因此得出结论,对CaSki和HPK IA细胞的反应性是由于对同种异体HLA分子的交叉反应而非对E7的识别,这强调了肽诱导的CTL对肿瘤细胞的裂解特异性必须谨慎解读。

相似文献

1
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.由人乳头瘤病毒16型E7衍生肽诱导的人细胞毒性T淋巴细胞的特异性
J Gen Virol. 1997 Jul;78 ( Pt 7):1689-95. doi: 10.1099/0022-1317-78-7-1689.
2
HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions.人乳头瘤病毒16型E6和E7蛋白对肿瘤性宫颈病变患者的HLA - A2限制性外周血细胞溶解性T淋巴细胞反应
Cancer Immunol Immunother. 1996 Mar;42(3):151-60. doi: 10.1007/s002620050265.
3
Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.E7脉冲自体树突状细胞对16型和18型人乳头瘤病毒阳性宫颈癌患者人乳头瘤病毒特异性CD4(+)和CD8(+)淋巴细胞的诱导作用
J Virol. 1999 Jul;73(7):5402-10. doi: 10.1128/JVI.73.7.5402-5410.1999.
4
Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.宫颈癌患者中针对人乳头瘤病毒16型E7肽的CD8 + T细胞与冠状病毒NS2蛋白发生交叉反应。
J Virol. 2003 May;77(9):5464-74. doi: 10.1128/jvi.77.9.5464-5474.2003.
5
Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigens.用CD80基因转染的宫颈癌细胞引发针对人乳头瘤病毒16型E7抗原的原发性细胞毒性T淋巴细胞反应。
Cancer Gene Ther. 1997 Nov-Dec;4(6):377-82.
6
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.使用荧光组织相容性白细胞抗原-A*0201/人乳头瘤病毒16型E7肽复合物分离识别内源性人乳头瘤病毒抗原的罕见人类细胞毒性T淋巴细胞。
Cancer Res. 2000 Jan 15;60(2):365-71.
7
Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.合成肽可诱导针对18型人乳头瘤病毒的细胞毒性反应。
Gynecol Oncol. 2001 Jul;82(1):77-83. doi: 10.1006/gyno.2001.6205.
8
Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer.用人乳头瘤病毒16型E7肽脉冲树突状细胞刺激产生肿瘤特异性细胞毒性T淋巴细胞:一种宫颈癌免疫治疗方法
Gynecol Oncol. 1999 Sep;74(3):448-55. doi: 10.1006/gyno.1999.5504.
9
Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.基于树突状细胞的宫颈癌疫苗I:用重组蛋白脉冲树突状细胞进行体外刺激可诱导针对HPV16 E7或HPV18 E7的特异性T细胞。
J Cancer Res Clin Oncol. 2003 Sep;129(9):511-20. doi: 10.1007/s00432-003-0462-6. Epub 2003 Aug 2.
10
Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.宫颈癌的基因免疫:用表达人乳头瘤病毒16型E6和E7的重组甲病毒载体诱导细胞毒性T淋巴细胞活性
Gene Ther. 2000 Nov;7(21):1859-66. doi: 10.1038/sj.gt.3301257.

引用本文的文献

1
Immunotherapy for HPV Malignancies.HPV 相关恶性肿瘤的免疫治疗。
Semin Radiat Oncol. 2021 Oct;31(4):361-370. doi: 10.1016/j.semradonc.2021.02.008.
2
Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy.鉴定新型免疫原性人乳头瘤病毒16型E7特异性表位,其受限于HLA - A*33:03,用于宫颈癌免疫治疗。
Yonsei Med J. 2017 Jan;58(1):43-50. doi: 10.3349/ymj.2017.58.1.43.
3
A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.
一种采用表达基因减毒E6蛋白的DNA/禽痘重组体的初免/加强免疫策略,作为针对HPV-16相关癌症的一种假定疫苗。
J Transl Med. 2015 Mar 5;13:80. doi: 10.1186/s12967-015-0437-9.
4
A microarray method for identifying tumor antigens by screening a tumor cDNA expression library against cancer sera.一种通过筛选肿瘤 cDNA 表达文库与癌症血清反应来鉴定肿瘤抗原的微阵列方法。
Hum Vaccin Immunother. 2013 Oct;9(10):2178-88. doi: 10.4161/hv.25634. Epub 2013 Jul 12.
5
Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.利用 TCR 基因转移生成 HPV 特异性辅助性 T 细胞治疗 HPV 诱导的恶性肿瘤。
J Transl Med. 2011 Sep 5;9:147. doi: 10.1186/1479-5876-9-147.
6
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.使用源自人MUTZ-3细胞系的同种异体树突状细胞对肿瘤特异性细胞毒性T淋巴细胞进行体外致敏。
Cancer Immunol Immunother. 2006 Dec;55(12):1480-90. doi: 10.1007/s00262-006-0142-x. Epub 2006 Feb 9.
7
Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.编码嵌合型乙型肝炎病毒表面抗原-16型人乳头瘤病毒E7蛋白的低剂量腺病毒疫苗可诱导增强的E7特异性抗体和细胞毒性T细胞反应。
J Virol. 2005 Oct;79(20):12807-17. doi: 10.1128/JVI.79.20.12807-12817.2005.
8
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.不同级别宫颈肿瘤女性中针对16型人乳头瘤病毒的T细胞反应。
Br J Cancer. 2005 Jul 25;93(2):248-59. doi: 10.1038/sj.bjc.6602679.
9
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.通过血清学表达克隆鉴定肿瘤抗原作为免疫治疗的潜在靶抗原。
Cancer Immunol Immunother. 2004 Mar;53(3):144-7. doi: 10.1007/s00262-003-0470-z. Epub 2004 Jan 15.
10
Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.通过T细胞受体分析和对自体肿瘤的识别证明,宫颈癌患者存在抗原驱动的T细胞选择。
Clin Diagn Lab Immunol. 2002 Mar;9(2):267-78. doi: 10.1128/cdli.9.2.267-278.2002.